Opinion Published In: April, 2017 | |
Are we Satisfactorily Managing Type-2 Diabetes Mellitus Patients? | |
Munnichoodappa C* | |
Mini Review Published In: April, 2017 | |
New Data on Cardiovascular Effects of Glucagon- Like Peptide-1 Receptor Agonists | |
Anastasios Tentolouris, Ioanna Eleftheriadou and Nikolaos Tentolouris* | |
Short communication Published In: April, 2017 | |
Patient Retention Stewardship in Real world Evidence Studies: the Pentad of P’s Model | |
Amit Kumar1*, Sanjay Kalra2 and Vandna Rana3 | |
Mini Rewiew Published In: April, 2017 | |
Diabetic Nephropathy: What is Best Therapeutic Option? | |
Maryam Zain* | |
Mini Rewiew Published In: April, 2017 | |
Is Telomere Shortening a Genetic Factor That Predisposes to Diabetes Mellitus 2 and Oxidative Stress, or do They Induce It? A Telomere Shortening Predisposes to T2DM | |
Murillo Ortiz Blanca* and Martínez Garza Sandra | |